QSAM Biosciences Provides 2022 Update and 2023 Milestones to Shareholders
10 janv. 2023 07h00 HE
|
QSAM Biosciences Inc.
AUSTIN, Texas, Jan. 10, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...
Nusano Announces Appointment of Chris Lowe as Chief Executive Officer
13 déc. 2022 10h00 HE
|
Nusano
VALENCIA, Calif. and WEST VALLEY CITY, Utah, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced Chris Lowe as the...
During the Forecast Period Ranging from 2022-32, Global Radiopharmaceuticals Market Uptake is Anticipated to Flourish at a Value CAGR of 4.3% to Reach US$ 9.5 Bn | Future Market Insights, Inc.
26 oct. 2022 09h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Oct. 26, 2022 (GLOBE NEWSWIRE) -- NEWARK, Del: The global radiopharmaceuticals market stands at US$ 6.2 Bn as of now and is expected to reach US$ 9.5 Bn by the year 2032 at a CAGR of...
QSAM Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
17 mai 2022 08h00 HE
|
QSAM Biosciences Inc.
Dosed First Patient in Phase 1 Clinical Program Evaluating CycloSam® Radiopharmaceutical Drug Candidate for Treatment of Metastatic Bone Cancer Austin, TX, May 17, 2022 (GLOBE NEWSWIRE) -- QSAM...
Telix Radiopharmaceutical Production Facility Buildout Commences
21 mars 2022 18h41 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and BRUSSELS, Belgium, March 22, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to provide a material update on the development...
QSAM Biosciences Appoints Adriann Sax to Board of Directors
25 janv. 2022 08h30 HE
|
QSAM Biosciences Inc.
Austin, TX, Jan. 25, 2022 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...
RAFA To Add Major Component to the Tashkent Pharma Park
17 déc. 2021 11h34 HE
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and the Czech company “Block” signed an agreement on the implementation of the construction of a...
Radiotherapy Market Size Worth $10,170.80 Million, Globally, by 2028 at 5.9% CAGR - Exclusive Report by The Insight Partners
16 déc. 2021 13h44 HE
|
The Insight Partners
New York, Dec. 17, 2021 (GLOBE NEWSWIRE) -- According to the new market research report "Radiotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (External-Beam Radiation...
Radionetics Oncology Emerges from Crinetics Pharmaceuticals with a Platform and Deep Pipeline of Nonpeptide Targeted Radiopharmaceutical Drug Candidates for Precision Oncology
18 oct. 2021 16h00 HE
|
Crinetics Pharmaceuticals, Inc.
Co-founded by Crinetics, 5AM Ventures and Frazier Healthcare Partners, the New Company Launches with $30M in Initial Financing Provided by 5AM and Frazier Pipeline is Built from Crinetics’ Core...
Radiopharmaceuticals Market ($13.81Bn by 2028) Growth Forecast at 9% CAGR During (2021-2028) - COVID-19 Impact and Global Analysis by TheInsightPartners.com
24 août 2021 15h06 HE
|
The Insight Partners
New York, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Radiopharmaceuticals Market: Key InsightsAccording to our new research study on “Radiopharmaceuticals Market to 2028 – Global Analysis and Forecast – by...